[1]
Awad, N.A. et al. 2016. Hybrid nanoliposome as a targeted growth inhibitor for Cervical Carcinoma Cell line. Journal of the Faculty of Medicine Baghdad. 57, 4 (Jan. 2016), 320–324. DOI:https://doi.org/10.32007/jfacmedbagdad.574399.